Research of anti-tumor effect of PH II-7 to K562/A02 cells

Chinese Pharmacological Bulletin

Volumn 26, Issue 6, 2010, Pages 750-753

  Li, Xiang Shang ^a   Lin, Yang ^a   Hu, Yun Hui ^a   Su, Ye ^a   Cheng, Xin ^a   Yang, Ming ^a   Yang, Chun Zheng ^a   Wang, Jin Hong ^a  

^a INSTITUTE OF HEMATOLOGY AND BLOOD DISEASES HOSPITAL   (China)

Author keywords

MDR1; Multidrug resistance; Oxindoles; Pgp; PH II 7

Indexed keywords

EID: 77956801542     PISSN: 10011978     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (8)

1. McDevitt C A, Callaghan R. How can we best use structural information on P-glycoprotein to design inhibitors [J]? Pharmacol Ther, 2007, 113(2):429-41. (Pubitemid 46149055)
2. Huang D W, Sherman B T, Lempicki R A. Systematic and integrative analysis of large gene lists using DAVID bioinformatics resources [J]. Nat Protoc, 2009, 4(1):44-57.
3. Widmer N, Rumpold H, Untergasser G, et al. Resistance reversal by RNAi silencing of MDR1 in CML cells associated with increase in imatinib intracellular levels [J]. Leukemia 2007, 21(7):1561-2.
4. Celius T, Garberg P, Lundgren B. Stable suppression of MDR1 gene expression and function by RNAi in Caco-2 cells [J]. Biochem Biophys Res Commun, 2004, 324(1):365-71. (Pubitemid 39311504)
5. Tan Y H, Yang C Z, Qi J, et al. Effects of 3-substituted aryl oxindole (PH II-7) on cell cycle of tumor cells [J]. Acta Pharmacol Sin, 2003, 38(11):802-8.
6. Zhou Y, Wang C Y, Su Y, et al. Intracellular localization of 3-substituted aryl oxindole (PH II-7) [J]. Chin Pharmacol Bull, 2009, 25(6):751-4.
7. Wang L, Ke H, Wang Y Y, et al. Changes of the distribution and accumulation of adriamycin in the sensitive and multidrug-resistant HL-60 cells [J]. Mol Pharmacol, 1993, 43(6):858-62.
8. Jiang X F, Zhen Y S. Reversal of multidrug resistance by emodin in cancer cells [J]. Acta Pharmacol Sin, 1999, 34(3):164-7.